A selective membrane-disrupting peptide discovered in 2000 shows promise for targeting cancer cells while sparing healthy tissue—so why isn't it in clinical use yet?
PNC-27: The Cancer-Killing Peptide That's…
A selective membrane-disrupting peptide discovered in 2000 shows promise for targeting cancer cells while sparing healthy tissue—so why isn't it in clinical use yet?